Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cells.

Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cells. J Natl Cancer Inst. 1980 Feb; 64(2):365-72.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.